Marycliff Allergy Specialists

Spokane, Washington 99204

0 studies enrolling now · 10 studies all time

What they study most

Agammaglobulinemia, Antibody Deficiency, Hereditary Angioedema, Hereditary Angioedema (HAE), Hypogammaglobulinemia, Perennial Allergic Rhinitis, Primary Immunodeficiency, Type I Hypersensitivity

Studies at this site

• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration — Completed
• C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks — Completed
• Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks — Completed
• Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks — Completed
• CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 — Completed
• Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) — Completed
• Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks — Completed
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis — Completed
• Efficacy and Safety/Tolerability of Grass MATA MPL — Completed